Navigation Links
Amgen And Servier Announce Product Collaboration
Date:7/9/2013

or heart failure and angina. Ivabradine, an If inhibitor, offers a novel alternative approach for patients with elevated heart rates. We value Servier's extensive experience in cardiovascular disease and look forward to working with them as Amgen continues to build our presence in this area."

"Servier is very pleased to establish a collaboration with Amgen, a leading biotechnology company with a unique track record of bringing innovative medicines to patients. This is a clear recognition of the medical value of ivabradine, one of our major cardiovascular innovations, which could also benefit U.S. patients," said Jean-Philippe Seta, M.D., chief executive officer at Servier.

"Ivabradine is a first-in-class innovative drug for the treatment of heart failure and angina. The clinical benefit and safety profile are supported by the results of clinical studies performed or being performed in more than 40,000 patients. I strongly believe that Servier's expertise in heart failure will complement Amgen's efforts in making omecamtiv mecarbil, a very innovative and complementary approach to treating heart failure, available to patients in Europe," said Emmanuel Canet, M.D., Ph.D., head of Research and Development at Servier.

Ivabradine is an If inhibitor approved by the European Medicines Agency in 2005 for the symptomatic treatment of stable angina and in 2012 for chronic heart failure, as well as approved in more than 100 other countries, excluding the U.S. Omecamtiv mecarbil activates cardiac muscle contractility and operates to strengthen heart function in patients with systolic dysfunction. Omecamtiv mecarbil is in Phase 2 studies and is being developed under a collaboration between Cytokinetics and Amgen.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen
'/>"/>

SOURCE Amgen; Servier
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations
2. Amgen And AstraZeneca Highlight Data To Be Presented At European League Against Rheumatism Annual Meeting
3. Amgen Announces Top-Line Results Of Phase 3 Talimogene Laherparepvec Trial In Melanoma
4. Amgen Announces 2013 Second Quarter Dividend
5. A Look Inside, Factors of Health - Research Report on Novogen Limited, Sanofi SA, ISIS Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.
6. Amgen Announces Webcast of 2012 Fourth Quarter and Full Year Financial Results
7. Amgen Highlights Data To Be Presented At American Society of Hematology Annual Meeting
8. Amgen To Present At The 24th Annual Piper Jaffray Healthcare Conference
9. Amgen Names Ray Jordan Senior Vice President, Corporate Affairs
10. Amgen Announces 2012 Third Quarter Dividend
11. Amgen to Present at the Leerink Swann Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... OMICS Group International invites researchers, authors and ... ‘Open Access Week’ by actively contributing their research ... Journals from 20-26th October, 2014. , Pharmaceutical ... accelerating with a tremendous speed to provide improved ... industry is gearing with innovation and technological revolution ...
(Date:9/18/2014)... 2014 SeqLL Inc., the owner ... announced today the closing of a $1M Series-A ... Genomic Diagnostic Technologies, will increase the power of ... Founded in March 2013 by Daniel Jones, a ... Helicos BioSciences, SeqLL has continued to offer Helicos’ ...
(Date:9/18/2014)... group of rare diseases that afflict skeletal growth ... hits at the fetal stage and is caused ... encoding fibroblast growth factor receptor 3 (FGFR3) has ... thanatophoric dysplasia (TD), a skeletal dysplasia that cause ... lethal, and achondroplasia (ACH), which causes stunted growth ...
(Date:9/18/2014)... Furnishing a research lab can be pretty expensive. Now ... University has published an open-source library of designs that ... used piece of equipment: the syringe pump. , Syringe ... as for drug delivery or mixing chemicals in a ... of dollars. , Joshua Pearce and his team of ...
Breaking Biology Technology:Pharma and Omics Journals to Address Global Challenges during Open Access Week 2Pharma and Omics Journals to Address Global Challenges during Open Access Week 3SeqLL Closes Series-A Funding Round for Expansion of Single Molecule Sequencing 2Researchers use iPS cells to show statin effects on diseased bone 2Researchers use iPS cells to show statin effects on diseased bone 3Doing science just got cheaper -- and faster 2
... 2011 Sanford Rose Associates® - San Francisco, a ... in the Life Sciences arena, welcomes Eduard Alberts, Ph.D. ... has over 20 years of experience and success in ... well as across different-sized companies and a wide array ...
... 2011 Cord Blood America, Inc . ( http://www.cordblood-america.com ... cord blood stem cell preservation company focused on ... nationwide and internationally, announced today it has entered into agreement ... to offer the storage of umbilical cord blood to its ...
... -- A research team led by University at Buffalo ... electron clouds on the surface of graphene, producing a ... in the remarkable material can harm its conductivity. , ... Communications, was conducted by UB, the National Institute of ...
Cached Biology Technology:Eduard Alberts, Ph.D. Joins Sanford Rose Associates - San Francisco 2Cord Blood America Enters Agreement With Horizon Healthcare Services, Inc. to Offer Stem Cell Collection Services to Its Members 2Researchers image graphene electron clouds, revealing how folds can harm conductivity 2Researchers image graphene electron clouds, revealing how folds can harm conductivity 3Researchers image graphene electron clouds, revealing how folds can harm conductivity 4
(Date:9/17/2014)... A UT Arlington engineering professor and his doctoral student ... that can accumulate water collected from fog and dew., ... the world or deserts around the globe., Cheng Luo, ... Xin Heng, PhD candidate in the same College of ... Aug. 25 edition of ACS, (American Chemical Society) ...
(Date:9/17/2014)... disposable plastic shopping bags and their environmental impact recently ... the first statewide ban on the bags, and Governor ... plastic bag industry is not yielding without a fight, ... News , the weekly newsmagazine of the American Chemical ... reports that the anti-bag campaign logged its first small ...
(Date:9/17/2014)... Researchers at the Catalan Institute of Oncology-Bellvitge Biomedical ... identified 5 genes differentially expressed in normal accompanying ... could be used to classify colorectal tumors, predict ... appropriate clinical decisions to prevent relapses. , ... most common in our population considering both sexes. ...
Breaking Biology News(10 mins):Shorebird's beak inspires UT Arlington research on water collection 2Five genes to predict colorectal cancer relapses 2
... lateral sclerosis (ALS) is a fatal disease that damages ... disease causes progressive paralysis of voluntary muscles and often ... Gehrig,s disease) was discovered over a century ago, neither ... several mechanisms seem to play a role in its ...
... Exercise has many benefits for adults, teens, and youngsters. ... may have during fetal growth during gestation. Now that ... no significant risk to a fetus, studies are underway ... study is now complete. Entitled The Effects of Maternal ...
... contraceptives (OC) yet its effect on their body composition and ... researchers has now examined the effects of OC on female ... gains in young women, and is associated with lower hormone ... study entitled Oral Contraceptive Use Impairs Muscle Gains in Young ...
Cached Biology News:Caffeine appears to be beneficial in males -- but not females -- with Lou Gehrig's disease 2Caffeine appears to be beneficial in males -- but not females -- with Lou Gehrig's disease 3Effects of maternal exercise on fetal breathing movements 2Oral contraceptives impair muscle gains in young women 2
... The Sub-Plates are E.Coli glycerol stocks contained ... contains 50 cDNA clones with approximately 5,000 ... the a master plate well, the corresponding ... PCR to identify the positive well(s). Cells ...
... 0.9 ml per liter of urine will give ... or BMD dipstick. ,Certification: The Donors are ... found to be NEGATIVE for HbsAg, HCV, HIV-1 ... approved FDA methods. THIS MATERIAL IS SOLD FOR ...
One controller two vessel system suitable for early stage of fermentation, and small scale, Application : cultivation of microorganisms and human or animal cells...
... light production by luciferase-cDNA transfected cell lines ... in the development of reporter gene assays ... an indicator for the transcription of other ... is due to advantages such as high ...
Biology Products: